Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Observational Study to Evaluate the Impact of Educational Material on the Compliance and Persistence Rates to Adjuvant Aromatase Inhibitor (AI) Medication for Postmenopausal Woman

NCT00681122 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00681122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00681122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Observational Study to Evaluate the Impact of Educational Material on the Compliance and Persistence Rates to Adjuvant Aromatase Inhibitor (AI) Medication for Postmenopausal Woman
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
May 31, 2011
Enrollment
2,600 (estimated)
Sites
164

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer